Clinical Study

Autosomal Dominant Polycystic Kidney Disease (Adpkd) Testing An Investigational Drug

Posted Date: Aug 22, 2016

  • Investigator: Shashi Kant
  • Specialties:
  • Type of Study: Drug

This study will evaluate the safety and effectiveness of an investigational medication called tolvaptan in patients with late stage 2 to early stage 4 chronic kidney disease caused by autosomal dominant polycystic kidney disease (ADPKD). The kidney function of participants will be checked through frequent blood tests.


You May Be Able To Join The Study If You Are: • Between The Ages Of 18 To 55 Years Old; Patients Aged 56 To 65 May Be Able To Participate In Some Circumstances • Diagnosed With Adpkd


Polycystic, Tolvaptan, Kidney, Autosomal

For More Information:

Angela Gordon
513-281-0091 ext 117

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.